SQSTM1 and breast carcinoma: Further supporting a role of p62 in oncogenesis and as a potential CAF target, a p62-encoding DNA vaccine exhibited strong antitumor and anti-metastasis activity in four mouse tumor models, including mammary carcinoma [46].